Effects of Message Framing and Time Discounting on Health Communication for Optimum Cardiovascular Disease and Stroke Prevention (EMT-OCSP)
Primary Purpose
Cardiovascular Disease, Stroke, Primary Prevention
Status
Completed
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
The strategic use of messages in risk communication
Sponsored by

About this trial
This is an interventional prevention trial for Cardiovascular Disease
Eligibility Criteria
Inclusion Criteria:
- aged 45-80 years,
- personally own and use a smartphone (Apple or Android platform) with Internet access,
- and have at least one of the following CVD risk factors: history of CVD at age < 60 years in a first-degree relative, smoking, diabetes, hypertension, and low-density lipoprotein (LDL)cholesterol ≥ 4.5 mmol/L.
Exclusion Criteria:
- participants with histories of CVD, heart failure, or chronic kidney disease (estimated glomerular filtration rate < 30 mL/min/1.73m2);
- those with terminal malignancy at baseline;
- those with severe psychological or mental disorders
- violation of the study protocol and participation in another clinical study during follow-up
Sites / Locations
- Health center of Sipo town
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Other
Other
Other
Other
Arm Label
Model A
Model B
Model C
Model D
Arm Description
Total cardiovascular disease (CVD)-free life expectancy gain in one's remaining life.
Average CVD-free life expectancy gain per year.
Total CVD-free life expectancy loss that can be reclaimed in one's remaining life.
Average CVD-free life expectancy loss that can be reclaimed per year.
Outcomes
Primary Outcome Measures
10-year CVD risk
Lifetime CVD risk
CVD-free life expectancy
Secondary Outcome Measures
Changes in systolic and diastolic blood pressure
Changes in serum cholesterol level
Changes in serum LDL level
Changes in serum non-HDL level
Changes in serum triglycerides level
Changes in fasting glucose level
Changes in physical activity (International Physical Activity Questionnaire or International Physical Activity Questionnaire Short Version Modified for Elderly)
Changes in tobacco use
Tobacco use status (current, former, never) in the records at visits
Changes in alcohol use (AUDIT questionnaire)
Changes in dietary habits (food frequency questionnaire)
Changes adherence to pharmacological treatments for hypertension (proportion of persistent medication user)
A persistent medication user is defined as a participant who has purchased the drug at least once during each 3-month interval during our study.
Changes adherence to pharmacological treatments for dyslipidaemia (proportion of persistent medication user)
Changes adherence to pharmacological treatments for diabetes (proportion of persistent medication user)
Changes adherence to anti-thrombotic therapy (proportion of persistent medication user)
Full Information
NCT ID
NCT04450888
First Posted
June 11, 2020
Last Updated
March 9, 2022
Sponsor
West China Hospital
Collaborators
Centers for Disease Control and Prevention, China, Beijing Tiantan Hospital, First Affiliated Hospital of Chongqing Medical University, China Stroke Databank Center
1. Study Identification
Unique Protocol Identification Number
NCT04450888
Brief Title
Effects of Message Framing and Time Discounting on Health Communication for Optimum Cardiovascular Disease and Stroke Prevention
Acronym
EMT-OCSP
Official Title
Effects of Message Framing and Time Discounting on Health Communication for Optimum Cardiovascular Disease and Stroke Prevention(EMT-OCSP): a Pragmatic,Multi-centre, Observer-blinded,12-month Randomised Controlled Study
Study Type
Interventional
2. Study Status
Record Verification Date
March 2022
Overall Recruitment Status
Completed
Study Start Date
July 1, 2020 (Actual)
Primary Completion Date
January 22, 2022 (Actual)
Study Completion Date
January 22, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
West China Hospital
Collaborators
Centers for Disease Control and Prevention, China, Beijing Tiantan Hospital, First Affiliated Hospital of Chongqing Medical University, China Stroke Databank Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Effects of Message framing and Time discounting on heath communication for Optimum Cardiovascular disease and Stroke Prevention(EMT-OCSP)is a pragmatic, 2 × 2 factorial, randomized, controlled, observer blinded, multicenter trial with four parallel groups. It aims to determine if risk and intervention communication strategy(gain-framed versus loss-frame, long-term context versus short-term context and the potential interaction)have different effect on optimizing adherence to clinical preventive management (in the endpoint of CVD risk reduction)for subjects with at least one moldable risk factor for CVD.
Detailed Description
Scientific title Effects of Message framing and Time discounting on health communication for Optimum Cardiovascular disease and Stroke Prevention(EMT-OCSP): a pragmatic randomised controlled study
Principal Investigator Li He
Study period 2020-07-01-2022-01-21
Hypotheses and aims When communicating cardiovascular disease(CVD)risk to individuals, different presentation of information carries its own connotations and biases. The one or the other pattern of the presentation may affect individuals' decision making.This study aims to determine if risk and intervention communication strategy(gain-framed versus loss-frame, long-term context versus short-term context and the potential interaction)have different effect on optimizing adherence to clinical preventive management (in the endpoint of CVD risk reduction)for subjects with at least one moldable risk factor for CVD. We aim to provide evidence for practitioners regarding messaging strategies that improve communication effectiveness and further reduce the risk of CVD events in the population, as well as to develop more effective communication strategies for groups of people with different characteristics to maximise patient adherence to lifestyle modifications and medical treatment.
Primary outcome Ten-year CVD risk, lifetime CVD risk and CVD-free life expectancy after 1 year according to the LIFE-CVD model.
Secondary outcomes CVD risk factors [blood pressure(BP) and serum cholesterol, low-density lipoprotein (LDL), non-high-density lipoprotein (HDL), triglycerides and fasting glucose levels],lifestyle factors (physical activity, tobacco use, alcohol use and eating habits), pharmacological treatments for hypertension, dyslipidaemia and diabetes, and anti-thrombotic drug prescriptions after 1 year.
Study design The EMT-OCSP trial is designed as a pragmatic, 2 × 2 factorial, randomized, controlled, observer blinded, multicenter trial with four parallel groups. Randomization will be performed as block randomization with a 1:1:1:1 allocation.
Study population and sample size Subjects with at least one moldable risk factor for CVD. The sample size calculations revealed that the enrolment of 15,000 participants would be sufficient, allowing for a 20% drop-out rate.
Follow-up period One year
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiovascular Disease, Stroke, Primary Prevention
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
13114 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Model A
Arm Type
Other
Arm Description
Total cardiovascular disease (CVD)-free life expectancy gain in one's remaining life.
Arm Title
Model B
Arm Type
Other
Arm Description
Average CVD-free life expectancy gain per year.
Arm Title
Model C
Arm Type
Other
Arm Description
Total CVD-free life expectancy loss that can be reclaimed in one's remaining life.
Arm Title
Model D
Arm Type
Other
Arm Description
Average CVD-free life expectancy loss that can be reclaimed per year.
Intervention Type
Other
Intervention Name(s)
The strategic use of messages in risk communication
Intervention Description
The interventions in the EMT-OCSP study are strategic health messages delivered (gain-framed vs.loss-framed and long-term vs.short-term contexts) to individuals based on their calculated CVD-free life expectancy and potential interventional benefits.
Primary Outcome Measure Information:
Title
10-year CVD risk
Time Frame
At the 1-year follow-up
Title
Lifetime CVD risk
Time Frame
At the 1-year follow-up
Title
CVD-free life expectancy
Time Frame
At the 1-year follow-up
Secondary Outcome Measure Information:
Title
Changes in systolic and diastolic blood pressure
Time Frame
At the 1-year follow-up
Title
Changes in serum cholesterol level
Time Frame
At the 1-year follow-up
Title
Changes in serum LDL level
Time Frame
At the 1-year follow-up
Title
Changes in serum non-HDL level
Time Frame
At the 1-year follow-up
Title
Changes in serum triglycerides level
Time Frame
At the 1-year follow-up
Title
Changes in fasting glucose level
Time Frame
At the 1-year follow-up
Title
Changes in physical activity (International Physical Activity Questionnaire or International Physical Activity Questionnaire Short Version Modified for Elderly)
Time Frame
At the 1-year follow-up
Title
Changes in tobacco use
Description
Tobacco use status (current, former, never) in the records at visits
Time Frame
At the 1-year follow-up
Title
Changes in alcohol use (AUDIT questionnaire)
Time Frame
At the 1-year follow-up
Title
Changes in dietary habits (food frequency questionnaire)
Time Frame
At the 1-year follow-up
Title
Changes adherence to pharmacological treatments for hypertension (proportion of persistent medication user)
Description
A persistent medication user is defined as a participant who has purchased the drug at least once during each 3-month interval during our study.
Time Frame
At the 1-year follow-up
Title
Changes adherence to pharmacological treatments for dyslipidaemia (proportion of persistent medication user)
Time Frame
At the 1-year follow-up
Title
Changes adherence to pharmacological treatments for diabetes (proportion of persistent medication user)
Time Frame
At the 1-year follow-up
Title
Changes adherence to anti-thrombotic therapy (proportion of persistent medication user)
Time Frame
At the 1-year follow-up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
aged 45-80 years,
personally own and use a smartphone (Apple or Android platform) with Internet access,
and have at least one of the following CVD risk factors: history of CVD at age < 60 years in a first-degree relative, smoking, diabetes, hypertension, and low-density lipoprotein (LDL)cholesterol ≥ 4.5 mmol/L.
Exclusion Criteria:
participants with histories of CVD, heart failure, or chronic kidney disease (estimated glomerular filtration rate < 30 mL/min/1.73m2);
those with terminal malignancy at baseline;
those with severe psychological or mental disorders
violation of the study protocol and participation in another clinical study during follow-up
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Li He, M.D.
Organizational Affiliation
West China Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Health center of Sipo town
City
Yibin
State/Province
Sichuan
Country
China
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Researchers affiliated with the EMT-OCSP study will have access to an internal webpage listing available aggregated datasets and variables; they will not have access to individual data or the original database.External researchers collaborating with at least one steering group member may submit standardised applications for data via this webpage.Upon steering group approval, the data manager will export anonymised aggregated data to authorised researchers.
IPD Sharing Time Frame
6 months after publication
Citations:
PubMed Identifier
33762233
Citation
Zhou M, Guo J, Chen N, Ma M, Dong S, Li Y, Fang J, Zhang Y, Zhang Y, Bao J, Hong Y, Lu Y, Qin M, Yin L, Yang X, He Q, Ding X, Chen L, Wang Z, Mi S, Chen S, Zhu C, Zhou D, He L. Effects of Message Framing and Time Discounting on Health Communication for Optimum Cardiovascular Disease and Stroke Prevention (EMT-OCSP): a protocol for a pragmatic, multicentre, observer-blinded, 12-month randomised controlled study. BMJ Open. 2021 Mar 24;11(3):e043450. doi: 10.1136/bmjopen-2020-043450.
Results Reference
derived
Learn more about this trial
Effects of Message Framing and Time Discounting on Health Communication for Optimum Cardiovascular Disease and Stroke Prevention
We'll reach out to this number within 24 hrs